Dipeptidyl Peptidase-4 Inhibitors in Chronic Kidney Disease: A Systematic Review of Randomized Clinical Trials

Simon R. Walker,Paul Komenda,Suhail Khojah,Wafa Al-Tuwaijri,Kerry Macdonald,Brett Hiebert,Neil Tangri,Stewart Nadurak,Thomas W. Ferguson,Claudio Rigatto,Navdeep Tangri

Dipeptidyl Peptidase-4 Inhibitors in Chronic Kidney Disease: A Systematic Review of Randomized Clinical Trials

2017

Simon R. Walker
Paul Komenda
Suhail Khojah
Wafa Al-Tuwaijri
Kerry Macdonald
Brett Hiebert
Neil Tangri
Stewart Nadurak
Thomas W. Ferguson
Claudio Rigatto
Navdeep Tangri

Background: Chronic kidney disease(CKD) is common in patients with type 2 diabetes mellitus (T2DM) and limits therapeutic options. Dipeptidyl peptidase-4 (DPP-4)

Keywords:

Internal medicine
Dipeptidyl peptidase-4
Randomized controlled trial
Endocrinology
Diabetes mellitus
Kidney disease
Type 2 Diabetes Mellitus
Medicine
in patient

Correction
Source
Cite
Save

References

Citations